CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-13 | ABERNETHY MATT Chief Financial Officer | Option exercise 10b5-1 | +14,100 | $73.60 | $1.0M | 45,628 |
| 2024-08-13 | ABERNETHY MATT Chief Financial Officer | Sale 10b5-1 | −14,100 | $150.38 | $2.1M | 31,528 |
| 2024-08-13 | ABERNETHY MATT Chief Financial Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −14,100 | 0 | ||
| 2024-08-13 | Delaet Ingrid Chief Regulatory Officer | Option exercise 10b5-1 | +3,043 | $103.52 | $315K | 9,650 |
| 2024-08-13 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −3,043 | $150.13 | $457K | 6,607 |
| 2024-08-13 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −4,100 | $150.08 | $615K | 2,507 |
| 2024-08-13 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −3,043 | 22,049 | ||
| 2024-08-06 | Delaet Ingrid Chief Regulatory Officer | Option exercise 10b5-1 | +273 | $79.02 | $22K | 6,880 |
| 2024-08-06 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −273 | $147.70 | $40K | 6,607 |
| 2024-08-06 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −273 | 4,081 | ||
| 2024-08-01 | Cooke Julie Chief Human Resources Officer | Option exercise 10b5-1 | +12,632 | $61.82 | $781K | 30,834 |
| 2024-08-01 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −12,632 | $153.26 | $1.9M | 18,202 |
| 2024-08-01 | Cooke Julie Chief Human Resources Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −12,632 | 0 | ||
| 2024-08-01 | Lippoldt Darin Chief Legal Officer | Option exercise 10b5-1 | +2,996 | $79.02 | $237K | 42,736 |
| 2024-08-01 | Lippoldt Darin Chief Legal Officer | Sale 10b5-1 | −2,996 | $154.01 | $461K | 39,740 |
| 2024-08-01 | Lippoldt Darin Chief Legal Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −2,996 | 43,372 | ||
| 2024-07-16 | Cooke Julie Chief Human Resources Officer | Option exercise 10b5-1 | +900 | $61.82 | $56K | 19,102 |
| 2024-07-16 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −900 | $150.04 | $135K | 18,202 |
| 2024-07-16 | Cooke Julie Chief Human Resources Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −900 | 12,632 | ||
| 2024-07-16 | Delaet Ingrid Chief Regulatory Officer | Option exercise 10b5-1 | +400 | $103.52 | $41K | 7,907 |
Page 29 of 49 · 963 trades